Physician profile
Jared D Beck
NPI 1386083186
$888.25
in general payments reported to CMS, 2019-2025
20 companies · $70.36 in 2025
The $70.36 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $708 · 2022: $12.61 · 2023: $97.26 · 2025: $70.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138 · Education: $29.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.30 |
| Education | $29.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $192.72 | 2019-2023 | Breztri |
| Glaxosmithkline, LLC. | $78.70 | 2019-2022 | |
| Novo Nordisk INC | $66.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $64.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.14 | 2019 | |
| Amgen INC. | $57.45 | 2019 | |
| Astellas Pharma US INC | $57.44 | 2019-2023 | Myrbetriq |
| Exact Sciences Corporation | $47.52 | 2025 | The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.87 | 2019-2023 | Xifaxan |
| Abbott Laboratories | $35.71 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $27.42 | 2019 | |
| Lilly USA, LLC | $26.11 | 2019 | |
| Bioventus LLC | $24.10 | 2019 | |
| Insulet Corporation | $22.84 | 2025 | Omnipod |
| Merck Sharp & Dohme LLC | $16.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.46 | 2019 | |
| Mylan Specialty L.P. | $12.92 | 2019 | |
| Vifor Pharma, INC. | $12.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.